Medilink EM Directors

Keith Widdowson

Chairman

Keith has lived and managed regional pharmaceutical businesses in South Africa, Australia and also Asia Pacific from Singapore. Prior to that, he managed global pharmaceutical exports for Fisons from the UK. More recently, he has worked for 3i providing industry expertise for life science investments in Europe. Keith is now involved in pharmaceutical business consultancy and funding, as well as business mentoring.

Stefan Ogrodzinski

Stefan Ogrodzinski received his BSc (Hons) in Toxicology and Pharmacology from The School of Pharmacy, University of London, in 1987 and his MBA
 from De Montfort University in 1999. Stefan's career has spanned the pharmaceutical industry, the healthcare, voluntary and educational sectors. In 2000, Stefan founded Biostatus and since that time has led the company as its CEO.

Glenn Crocker

Glenn has a first degree in Genetics from The University of Nottingham and a D.Phil in Immunology from Oxford University. Following a period of post-doctoral research, Glenn joined Ernst & Young and qualified as a chartered accountant. He then spent several years in Palo Alto, Ca. as part of Ernst & Young’s biotech practice working with companies at varying stages of development. Since June 2003, Glenn has been Chief Executive of BioCity Nottingham Ltd.

Yvonne Barnett

Yvonne has a Bsc (Hons) Biomedical Science and PhD in Biochemistry and Genetics. She is Pro Vice Chancellor for Regional Engagement and Enterprise and Head of The College of Science at Nottingham Trent University. She has authored numerous peer-reviewed research papers and has long standing collaborations with Centres of Excellence worldwide. She represents NTU primarily in the area of technology and knowledge transfer (enterprise), on a number of regional and national bodies.

Ian MacDonald

Ian has B.Sc. and Ph.D degrees in Physiology from the University of London. He joined the University of Nottingham in 1977, was appointed Professor in 1991 and was Head of the School of Biomedical Sciences from 1997-2002. He is now Director of Research for the Faculty of Medicine. He is joint Editor of the International Journal of Obesity,  a civilian advisor on nutrition to the UK Ministry of Defence, a member of the Food Standards Agency’s Scientific Advisory Committee on Nutrition, and President of the (UK) Nutrition Society.

Faz Chowdhury

Faz is CEO of Nemaura Pharma Limited. He originally trained as a pharmaceutical scientist, and subsequently completed a Masters in Microsystems and Nanotechnology at Cranfield University , and undertook Doctoral Research at the University of Oxford on nano-drug delivery. His experience in the Pharma Industry spans product development, manufacturing, technical and corporate management. He has numerous patents in the field of drug delivery devices  and formulations.

Steve Clark

Steve has been the Sales & Marketing Manager of Hospital Aids, Northampton since 2002, following a 25 year career in the Financial Services sector, which included Directorships of TSB Bank & FG Watts (FS) Ltd. He helped steer Hospital Aids from a small UK based medical & health/safety devices manufacturer towards International recognition, with an emphasis on new & innovative product design. Having personally benefitted from Medilink’s support, he is keen to promote the networking opportunities & benefits available.

Peter Rose

Peter has a BSc (Hons) in Microbiology from the University of Sheffield and is a Medical Devices regulatory & quality expert with an additional specialism in sterilisation. Peter is the Managing Director of High Edge Consulting, which he established in 2002, and is an active Medilink member who regularly helps SMEs through their challenges. A seasoned speaker at various industry events, Peter is also a guest lecturer, at The University of Nottingham on the Medical Device Regulation module for a MSc course.

Carol Aries

Carol has a BSc (Hons) in Economics and Business Economics from Southampton University and an MBA from the Open University. Carol has 25 year experience working in the medical devices industry including a variety of roles in Sales and Marketing Management for both the UK and European markets and in Strategic Business Development. Carol is also a qualified Six Sigma Black Belt. She is currently seconded to the Department of Health working in the Innovations Division supporting the implementation of the Department of Health Innovation, Health and Wealth strategy.

Brian Thompson

Dr Brian Thomson qualified in Medicine from the University of Edinburgh and trained in medicine in Edinburgh, London and Cambridge before being appointed an Associate Professor and Honorary Consultant Physician in Nottingham in 1987. Dr Thomson has held MRC Training and Clinician Scientist Fellowships in London and Cambridge and was awarded a PhD in 1992. He has been Director of Research and Innovation and Deputy Medical Director at Nottingham University Hospitals NHS Trust (NUH) since 2007 and is the founder and Director of the Nottingham Health Science Biobank. Dr Thomson is committed to creating close and dynamic partnerships between the NHS, academia and industry.